Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
OCUL
#1782
Ocular Therapeutix, Inc.
8.940
0
-3.14%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-3.14%
Aylık değişim
-17.45%
6 aylık değişim
-22.26%
Yıllık değişim
-22.26%
Önceki kapanış
9.230
0
Open
8.940
0
Bid
Ask
Low
8.940
0
High
8.940
0
Hacim
212
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
OCUL
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
157.22 M
159.02 M
159.3 M
174 M
213.05 M
217.69 M
—
Valuation ratios
Enterprise value
940.57 M
965.95 M
817.99 M
1.22 B
2.15 B
1.91 B
6.09 B
Price to earnings ratio
-7.98
-7
-6.6
-7.48
-8.35
-8.55
-30.99
Price to sales ratio
17.58
21.21
19.24
26.57
35.13
43.75
124.69
Price to cash flow ratio
-9.44
-10.04
-8.01
-8.66
-10.39
-11.09
-38.15
Price to book ratio
0.97
4.29
0.88
1.22
1.71
3.47
7.28
Enterprise value to EBITDA ratio
29.65
34.18
-12.88
-20.42
-16.49
-125.77
-175.56
Profitability ratios
Return on assets %
0.07
0.11
0.16
0.15
0.17
0.08
0.56
Return on equity %
0.1
0.15
0.24
0.22
0.27
0.1
0.83
Return on invested capital %
—
—
—
—
—
-557.3
—
Gross margin %
89.88
92.8
88.2
85.56
87.8
87.97
349.53
Operating margin %
298.2
296.06
597.47
502.57
472.35
526.5
2 098.88
EBITDA margin %
16.78
12.9
-588.3
-13.2
-465
-517.09
-1 583.58
Net margin %
236.58
283.25
598.74
503.86
477.3
487.95
2 067.85
Liquidity ratios
Quick ratio
12.94
10.59
10.14
10.02
7.78
15.32
43.26
Current ratio
13.01
10.66
10.22
10.09
7.85
15.39
43.56
Inventory turnover
0.63
0.45
0.4
0.62
0.54
0.45
2.01
Asset turnover
0.03
0.04
0.02
0.03
0.03
0.02
0.11
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.14
0.15
0.17
0.15
0.17
0.09
0.59
Long term debt to total equity ratio
0.19
0.22
0.26
0.23
0.27
0.11
0.87
Per share metrics
Operating cash flow per share
0.22
0.25
0.26
0.32
0.28
0.29
1.15
EBIT per share
0.01
0.01
-0.38
-0.02
-0.37
-0.37
-1.14
EBITDA per share
0.02
0.01
-0.37
-0.01
-0.37
-0.37
-1.12
Total debt per share
—
—
—
—
—
—
—
Cash per share
2.56
2.48
2.06
2.27
1.87
3.94
10.14
Net current asset value per share
2.83
2.79
2.29
2.51
2.1
4.18
11.08
Tangible book value per share
2.11
1.99
1.57
1.77
1.4
3.49
8.24
Working capital per share
2.61
2.53
2.06
2.26
1.84
3.91
10.07
Book value per share
2.11
1.99
1.57
1.77
1.4
3.49
8.24
Haberler
Ocular Therapeutix CSO Heier 25 bin dolarlık hisse sattı
Ocular Therapeutix yöneticisi Kaiser 23 bin dolarlık hisse sattı
Ocular Therapeutix CSO Heier sells $25k in stock
Ocular Therapeutix chief development officer Kaiser sells $23k in stock
Ocular Therapeutix CEO’su Dugel 166 bin dolarlık hisse sattı
Ocular Therapeutix CEO Dugel sells $166k in stock
Ocular Therapeutix CMO Waheed 27 bin dolarlık hisse sattı
Waheed Nadia, Ocular Therapeutix CMO, sells $27k in stock
Needham, deneme sonuçları nedeniyle Ocular Therapeutix hisse hedefini düşürdü
Ocular Therapeutix CSO Nayak 93 bin dolarlık hisse satışı gerçekleştirdi
Ocular Therapeutix COO’su Notman 103.471 dolarlık hisse satışı gerçekleştirdi
Waheed, Ocular Therapeutix’in tıbbi direktörü, 71 bin dolarlık hisse satışı gerçekleştirdi